Agricultural technology and biotechnology company Abattis Bioceuticals Corp., on Wednesday, announced the launch of the flagship laboratory of its cannabis research subsidiary Northern Vine Canada Inc.
The Northern Vine laboratory “solidifies” Abattis’ “vision to become a fully integrated medicinal marijuana company,” a statement from the company said.
The head of the Vancouver-based Abattis also touted the importance of independent testing in the legalization of cannabis is the country.
“As Canada continues down the path to legalizing medical and recreational marijuana, quality regulation and health awareness are becoming more important than ever,” said Robert Abenante, president, and CEO of Abattis and Northern Vine. “As large quantities of legalized marijuana enter the marketplace, comprehensive independent testing should be a cornerstone of the legislation.”
Northern Vine Lab is licensed by Health Canada (Dealers License) for the possession of cannabis and related active ingredients, as well as the production of extracts for the purpose of analysis.
Northern Vine Labs product certification and quality assurances programs incorporate global best practices and procedures for application in the legal Canadian cannabis market.
Northern Vine has already begun taking samples from select licensed producers and is building a sales force to aggressively grow its client base.
“Although it is our goal to provide the best and most efficient customer service for our clients, it is our primary objective to perform the tests using the highest possible standards available,” said Katie Maloney, senior scientist at Northern Vine. “Our lab will give clients the peace of mind of independently verified testing while keeping their information strictly confidential.”
Abattis recently announced that it has signed an exclusive distribution agreement with Suzhou Raybot Material Tech Corp. Raybot has developed a technology capable of extracting legal cannabis derivatives such as cannabidiol (CBG), tetrahydrocannabinol (THC) and cannabigerol from marijuana or hemp.
Raybot is able to extract CBD from hemp to an above 99 per cent purity level, according to Abattis.
“Abattis is uniquely positioned to formulate and distribute innovative, high-quality products which could potentially revolutionize the way we treat patients for a variety of pains and illnesses as well as to develop advanced nutraceutical and cosmetic products for high-end markets,” said Dr. David Galvez, senior science advisor at Northern Vine.